Virtu Financial’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.51M Buy
71,906
+59,035
+459% +$4.72M 0.19% 58
2025
Q4
$1.23M Buy
12,871
+1,519
+13% +$149K 0.05% 277
2025
Q3
$1.11M Buy
+11,352
New +$1.18M 0.06% 293
2024
Q1
Sell
-11,393
Closed -$659K 1447
2023
Q4
$659K Buy
+11,393
New +$608K 0.05% 312
2023
Q3
Sell
-13,123
Closed -$710K 1345
2023
Q2
$710K Buy
+13,123
New +$685K 0.05% 304
2023
Q1
Sell
-5,646
Closed -$261K 1565
2022
Q4
$261K Buy
+5,646
New +$244K 0.03% 555
2020
Q4
Sell
-32,598
Closed -$1.25M 1453
2020
Q3
$1.25M Buy
32,598
+17,150
+111% +$661K 0.21% 98
2020
Q2
$542K Buy
+15,448
New +$556K 0.06% 347
2019
Q4
$248K Sell
5,488
-40,852
-88% -$1.71M 0.02% 794
2019
Q3
$1.89M Buy
+46,340
New +$1.96M 0.15% 123
2018
Q4
Sell
-5,217
Closed -$201K 1577
2018
Q3
$201K Buy
+5,217
New +$182K 0.01% 1072
2018
Q2
Sell
-18,421
Closed -$503K 1993
2018
Q1
$503K Sell
18,421
-51,825
-74% -$1.41M 0.03% 702
2017
Q4
$1.74M Buy
+70,246
New +$1.94M 0.09% 231
2017
Q1
Sell
-13,039
Closed -$282K 414
2016
Q4
$282K Buy
+13,039
New +$285K 0.03% 362

Other funds holding BSX

Virtu Financial's BSX Position: Q1 2026 in Review

Virtu Financial increased its Boston Scientific (BSX) stake by 459% in Q1 2026, buying an estimated $4.72M and bringing the position to 71,906 shares worth $4.51M. The position accounts for 0.19% of the portfolio, ranked #58.

Virtu Financial first reported a position in BSX in Q4 2016 and has held it in 14 quarters since. 1,671 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Virtu Financial held 71,906 shares of Boston Scientific worth $4.51M as of Q1 2026.
  • Virtu Financial bought 59,035 Boston Scientific shares in Q1 2026, an estimated $4.72M.
  • Boston Scientific made up 0.19% of Virtu Financial's portfolio in Q1 2026, its #58 holding.
  • Virtu Financial first reported a position in Boston Scientific in Q4 2016 and has held it in 14 quarters since.
  • 1,671 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.